Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Polish Researchers Cite Rutherrin PDT for Brain Cancer

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Sep 12, 2023 1:17pm

187 Views

Post# 35631882

RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

As I have said it's my opinion that it would be a waste of time raising $462K unless it was only to get them through this next quarter with the expectation that they will be able raise money for GBM or NSCLC from a much more favorable position. If the time frame were longer they would be forced to do a deal with the devil but we know from this last update that they are close to getting BTD. The idea that they were begging for money and all they could get was $462K seems ludicrous to me given what they have achieved in this trial and what they have on the go.